BioPharma Clinical Trials
Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Reg...
February 06, 2025 | News
Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel anti...
February 06, 2025 | News
Actinogen Medical Limited (ASX: ACW) has announced that the World Health Organization (WHO) has granted the nonproprietary name ‘emestedastat...
February 06, 2025 | News
Argent BioPharma Limited (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company, is pioneering a transformative approach to drug-resistant e...
February 06, 2025 | News
Akeso, Inc. is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/AK112-306) evaluating ivonescimab...
February 06, 2025 | News
Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, announced it has initiated ...
February 04, 2025 | News
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving comple...
February 03, 2025 | News
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant A...
January 31, 2025 | News
Kazia Therapeutics Limited an oncology-focused drug development company, is pleased to announce the regulatory approval and launch of a clinical trial eval...
January 31, 2025 | News
The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinica...
January 31, 2025 | News
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation product...
January 27, 2025 | News
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting mon...
January 27, 2025 | News
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from Natio...
January 24, 2025 | News
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its ...
January 24, 2025 | News
Most Read
Bio Jobs
News